Aloka Ultrasound and RFA Medical Combine Efforts to Bring State-of-the-Art Technology to the Operating Room.WALLINGFORD, Conn. -- Aloka Ultrasound (Wallingford, CT) and RFA RFA right frontoanterior (position of the fetus). Radiofrequency ablation (RFA) A procedure in which radiofrequency waves are used to destroy blood vessels and tissues. Mentioned in: Prenatal Surgery Medical (Fremont, CA) have agreed to combine efforts in promoting their respective medical devices used for ablative ablative (ăb`lətĭv') [Lat.,=carrying off], in Latin grammar, the case used in a number of circumstances, particularly with certain prepositions and in locating place or time. The term is also used in the grammar of some languages (e.g. procedures. Aloka's ultrasound technology is the imaging modality used to guide the placement of RFA Medical's HS-RFA[TM] bi-polar radio frequency ablation device during ablative procedures. Aloka and RFA Medical expect the alliance to increase and broaden awareness among surgeons of the important benefits provided by each company's complementary products. Each company will retain direct control of the sales process A sales process is a systematic approach for performing product or service sales. The reasons for having a sales process include seller and buyer risk management, achieving standardized customer interaction in sales and scalable revenue generation. for their individual devices. Aloka's Chief Operating Officer Chief Operating Officer (COO) The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. David Famiglietti commented, "We are excited to be working with RFA Medical as a way to further strengthen our leadership position in the IOUS IOUS Intraoperative Ultrasound IOUS Input Output Utility Subsystem [TM] (Intraoperative Ultrasound) market. We are extremely impressed with the advancements RFA Medical has made in the area of bi-polar radio frequency ablation with their HS-RFA[TM] technology, and especially pleased that they chose to design their laparoscopic Laparoscopic A minimally-invasive surgical or diagnostic procedure that uses a flexible endoscope (laparoscope) to view and operate on structures in the abdomen. Mentioned in: Obstetrical Emergencies device to operate with Aloka's exclusive end-fire laparoscopic transducer transducer, device that accepts an input of energy in one form and produces an output of energy in some other form, with a known, fixed relationship between the input and output. . We look forward to a long-term and mutually beneficial relationship with RFA Medical." RFA Medical's President Steven Daniel went on to say "We are also delighted to be working with such a progressive and forward-looking company as Aloka. We feel that together we can bring the technological benefits from both companies to our mutual current and future customers so that they can better care for their patients." About Aloka Aloka Company, Ltd. (TSE See Tokyo Stock Exchange. TSE 1. See Tokyo Stock Exchange (TSE). 2. See Toronto Stock Exchange (TSE). : 7704)--The Innovator in Ultrasound--has served the worldwide medical community for more than 50 years. As one of the longest continuously operating ultrasound companies in the world, Aloka is one of the most experienced and innovative firms in the diagnostic ultrasound diagnostic ultrasound n. Use of ultrasound to obtain images for medical diagnostic purposes. market with more than 200,000 ultrasound systems installed worldwide. Aloka's U.S. headquarters is located in Wallingford, CT. www.aloka.com About RFA Medical RFA Medical, Inc. is a privately held medical device company specializing in the area of oncology including devices for high speed bi-polar radio frequency ablation incorporating proprietary HS-RFA[TM] technology and devices for the pre-coagulation of tissue prior to resections. RFA Medical's headquarters is located in Fremont, CA. www.rfamedical.com Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements, the accuracy of which is necessarily subject to risks and uncertainties. Discussions regarding physician adoption, performance of the system, and other matters discussed in this release, may differ significantly from the discussion of such matters in the forward-looking statements. Such differences may be based upon factors such as strategic planning decisions by management, regulatory requirements, re-allocation of internal resources, decisions by insurance companies, scientific advances by third parties, and introduction of competitive products, as well as those factors set forth in the Company's most recent Reports. |
|
||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion